Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials

Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials

Saved in:

Bibliographic Details
Main Authors:	Wenji Pu, Wenqi Chen, Haiman Jing, Jishi Li, Yong Jiang, Shasha Li, Weijie Wen, Zhiyuan Xu, Jing Jin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	locally advanced rectal cancer short-course radiotherapy consolidation chemotherapy total neoadjuvant therapy neoadjuvant chemoradiotherapy pathological complete response
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1552188/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials
by: Wenji Pu, et al.
Published: (2024-12-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

Comparison of prognosis for T4b rectal cancer with different pelvic compartment involvement treated using neoadjuvant chemoradiotherapy and implications for refinement of the current T staging system: A retrospective cohort study
by: Yang-zi Zhang, et al.
Published: (2025-03-01)

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01)

Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01)

Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
by: Liu Maoxi, et al.
Published: (2023-07-01)

Prognostic Value of Tumor Regression Grade Combined with Pathological Lymph Node Status in Initially Node-Positive Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Dakui Luo, et al.
Published: (2025-01-01)

A management of patients achieving clinical complete response after neoadjuvant therapy and perspectives: on locally advanced rectal cancer
by: Yu-Xin Liu, et al.
Published: (2025-01-01)

Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
by: Yutian Lai, et al.
Published: (2025-01-01)

Combining Endoscopic Submucosal Dissection and Adjuvant Chemoradiotherapy or Radiotherapy for Effective Management of Rectal Cancer with Deep Submucosal Invasion: A Case Series
by: Ji Hye Park, et al.
Published: (2024-11-01)

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort
by: Wei-Xiang Qi, et al.
Published: (2025-01-01)

Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review
by: Liu F, et al.
Published: (2025-01-01)

Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
by: Zhifu Chen, et al.
Published: (2025-01-01)

Radiomics in rectal cancer: current status of use and advances in research
by: Wei-Qin Huang, et al.
Published: (2025-01-01)

Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study
by: Hai Zhang, et al.
Published: (2025-01-01)

How Do MRI Findings Influence Rectal Cancer Management?
by: Ayloor Seshadri Ramakrishnan, et al.

Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the NetherlandsResearch in context
by: Hanneke van Laarhoven, et al.
Published: (2025-02-01)

Preoperative radiotherapy combined with surgery versus surgery alone for primary retroperitoneal sarcoma: a meta-analysis
by: Young Rak Kim, et al.
Published: (2025-01-01)

Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
by: Huan Zhang, et al.
Published: (2025-01-01)

Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
by: Sung Uk Bae, et al.
Published: (2025-03-01)

Organ preservation strategies for rectal cancer treatment: tarts or trap?
by: ZHOU Yihang, ZENG Ziwei, KANG Liang
Published: (2024-09-01)

Analysis of clinical and pathological prognostic factors of survival in rectal adenocarcinoma treated with preoperative radiochemotherapy
by: Sarhan Sydney Saad, et al.
Published: (2025-02-01)

Radioresistance in rectal cancer: can nanoparticles turn the tide?
by: Diogo Coelho, et al.
Published: (2025-01-01)

Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis
by: Laiping Xie, et al.
Published: (2025-12-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Radiomics of magnetic resonance imaging for assessment of pathological complete response to neoadjuvant therapy and long-term survival in breast cancer
by: N. V. Petrova, et al.
Published: (2023-09-01)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
by: Mingxing Wang, et al.
Published: (2025-01-01)

Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers‐Based Model
by: Maria Colomba Comes, et al.
Published: (2024-12-01)

Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients
by: Yuying Wang, et al.
Published: (2025-01-01)

Impact of chemoradiotherapy for first primary lung cancer on the prognosis and re-chemoradiotherapy sensitivity of second primary lung cancer
by: Zhe Chen, et al.
Published: (2025-01-01)

Design of studies on neoadjuvant therapy for intrahepatic cholangiocarcinoma
by: Yuan Cheng, et al.
Published: (2025-01-01)

Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2025-02-01)

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series
by: Lingyu Tan, et al.
Published: (2025-01-01)

Study of the effectiveness of vacuum-aspiration breast biopsy in patients with complete clinical response after neoadjuvant polychemotherapy in complex treatment of breast cancer
by: K. V. Maksimov, et al.
Published: (2023-12-01)

Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01)

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results
by: M. V. Sedova, et al.
Published: (2023-09-01)

Pelvic Radiotherapy in Rectal Cancer Patients With Synchronous Potentially Treatable Liver Metastases
by: Yayu Huang, et al.
Published: (2025-01-01)

Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis
by: Linfeng Wang, et al.
Published: (2025-01-01)

Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis
by: Yonghe Chen, et al.
Published: (2025-01-01)